Ken Griffin Third Harmonic Bio, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$3.36 - $5.48 $95,760 - $156,180
-28,500 Reduced 50.62%
27,800 $150,000
Q1 2025

May 15, 2025
BUY
$3.25 - $11.17 $182,650 - $627,754
56,200 Added 56200.0%
56,300 $195,000
Q4 2024

Feb 14, 2025
SELL
$10.29 - $15.4 $72,030 - $107,800
-7,000 Reduced 98.59%
100 $1,000
Q3 2024

Nov 14, 2024
SELL
$10.86 - $15.0 $21,720 - $30,000
-2,000 Reduced 21.98%
7,100 $96,000
Q2 2024

Aug 14, 2024
BUY
$8.74 - $15.54 $79,534 - $141,414
9,100 New
9,100 $118,000

Others Institutions Holding THRD

# of Institutions
108
Shares Held
38.4M
Call Options Held
62.7K
Put Options Held
119K
View Full List

About Third Harmonic Bio, Inc.

THRD Quotes by TradingView
  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $217M
More about THRD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email